Follow The Filings

AMCR Amcor PLC

Materials, filed as AMCOR PLC (ORD), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by AMCR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AMCR insider trades
  • $2.8M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Stephen R. Scherger CFO
    Buy
    $1M 121,065 shares at $8.32 New stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
  2. Nicholas T. Long Director
    Buy
    $85K 10,000 shares at $8.54 +19% to stake
    Traded Nov 12, 2025 Filed Nov 14, 2025
  3. James T Glerum Jr. Director
    Buy
    $500K 59,945 shares at $8.34 +6264% to stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  4. Ian Wilson Executive Vice President
    Buy
    $660K 79,000 shares at $8.35 +23% to stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  5. Peter Konieczny CEO
    Buy
    $505K 60,000 shares at $8.41 +13% to stake
    Traded Nov 10, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 38 option exercises, 22 share withholdings for taxes, and 3 sales to cover taxes.

Congress

5 members of Congress traded AMCR in the last three years: 7 buys and 3 sales. 5 members listed it in 2025 annual reports.

All Congress trades
  1. Thomas H. Kean, Jr. R-NJ-7 Partial sale $1K–$15K Aug 10 filed Sep 12
  2. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  3. Dan Newhouse R-WA-4Spouse Buy $1K–$15K Jul 10 filed Jul 17
  4. Thomas H. Kean, Jr. R-NJ-7 Buy $1K–$15K May 14 filed Jun 18
  5. Thomas H. Kean, Jr. R-NJ-7 Buy $1K–$15K Mar 31 filed Apr 13
  6. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Dec 19, 2025 filed Jan 12

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
DEFA14A
DEFA14A
DEF 14A
DEFA14A
8-K 4.01,9.01
10-K
SCHEDULE 13G —
8-K 2.02,9.01
8-K 5.02,9.01
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 5.03
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 1.01,2.03,8.01,9.01
424B5
424B5

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $14.69B $13.64B $15.01B $23.51B
Gross profit $2.72B $2.71B $2.83B $4.69B
Gross margin * 18.5% 19.9% 18.9% 20.0%
Net income $1.05B $0.73B $0.511B $1.11B
Net margin * 7.1% 5.4% 3.4% 4.7%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $5.31B $4.96B $8.43B $9.33B
Total non-current assets $11.7B $11.56B $28.63B $27.77B
Total assets $17B $16.52B $37.07B $37.1B
Total current liabilities $4.48B $4.26B $6.99B $7.44B
Total non-current liabilities $8.44B $8.31B $18.34B $17.86B
Total equity $4.03B $3.88B $11.73B $11.79B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $1.26B $1.32B $1.39B $2.15B
Cash from investing -$0.309B -$0.476B -$2.1B -$0.524B
Cash from financing -$1.02B -$0.857B $0.91B -$1.34B
Net change in cash -$161M -$101M $239M $288M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.